Global brokerage stock recommendations: Zydus Lifesciences, Mphasis, KEI Industries & more; note down ratings and targets
Here's what UBS, Morgan Stanley, Jefferies, Goldman Sachs, and Macquarie make of stocks such as Zydus Lifesciences (ZYDUSLIFE), Mphasis (MPHASIS), and KEI Industries (KEI):
As Dalal Street enters the October 17 session, brokerages have several stocks on their radar.
Global brokerages stock recommendation: Zydus Lifesciences, Mphasis, KEI Industries & more; check out ratings and targets
Here's what UBS, Morgan Stanley, Jefferies, Goldman Sachs, and Macquarie make of stocks such as Zydus Lifesciences (ZYDUSLIFE), Mphasis (MPHASIS), and KEI Industries (KEI):
SRF share price target
UBS has a 'sell' call on SRF shares with a target of Rs 2,100.
Mphasis share price target
Morgan Stanley has maintained an 'equal-weight' rating on Mphasis shares with a target of Rs 3,200.
KEI Industries share price target
Jefferies has maintained a 'buy' call on KEI Industries shares with a target of Rs 5,720.
Goldman Sachs and UBS on KEI Industries stock
Goldman Sachs has maintained a 'neutral' rating on the KEI Industries stock with a target of Rs 4,130.
UBS has maintained a 'buy' call on KEI shares with a target of Rs 6,150.
Zydus Lifesciences share price target
Macquarie has maintained an 'outperform' rating on Zydus Lifesciences shares with a target of Rs 1,365.
Global brokerage stock recommendations: Zydus Lifesciences, Mphasis, KEI Industries & more; note down ratings and targets
Disclaimer: The views/suggestions/recommendations expressed here in this article are solely by investment experts. Zee Business suggests its readers consult their investment advisers before making any financial decision.